Meningitis A Vaccine Helping African Nations Pursue Disease’s Elimination

PATH Blog: Celebrating in Africa: the end of the reign of meningitis
Steve Davis, president and CEO of PATH, discusses progress against meningitis A in Africa, saying the bacterial infection has been nearly eliminated with the development and widespread use of the MenAfriVac vaccine (2/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.